Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock OTC
  1. 4 Grant or award SVP, General Counsel&Secretary acquired 9,167 shares (grant or award)
  2. 4 Grant or award EVP, CFO & Treasurer acquired 13,333 shares (grant or award)
  3. 4 Grant or award President and CEO acquired 42,000 shares (grant or award)
  4. 4 Open-market sale President and CEO sold 4,114 shares at $0.82 ($3,373)
  5. 4 Open-market sale President and CEO sold 3,622 shares at $0.79 ($2,861)
  6. 4 Open-market sale President and CEO sold 3,606 shares at $0.92 ($3,319)
  7. 4 Open-market sale President and CEO sold 3,589 shares at $1.27 ($4,558)
  8. 4 Open-market buy Director bought 41,140 shares at $1.22 ($49,985)
  9. 4 Open-market sale President and CEO sold 3,622 shares at an average $1.33 ($4,817)
  10. 4 Open-market sale EVP, CFO & Treasurer sold 6,913 shares at $1.33 ($9,203)
  11. 4 Open-market sale SVP, General Counsel&Secretary sold 3,888 shares at $1.33 ($5,176)
  12. 4 Open-market sale EVP & Chief Commercial Officer sold 7,415 shares at $1.33 ($9,872)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Planned sale President and CEO sold 3,722 shares at $1.72 ($6,402)
  16. 4 Planned sale EVP, Chief Development Officer sold 2,845 shares at $1.70 ($4,837)
  17. 4 Planned sale President and CEO sold 3,538 shares at $1.72 ($6,085)
  18. 4 Planned sale EVP & Chief Commercial Officer sold 1,839 shares at $2.35 ($4,322)
  19. 4 Planned sale President and CEO sold 3,536 shares at $2.24 ($7,922)
  20. 4 Planned sale EVP, CFO & Treasurer sold 631 shares at $2.22 ($1,401)

Page 7 of 31 · 601 filings